Targeted therapy Leveraging ADCC to enhance anti-HER2 therapy

被引：5
|
作者：
Killock, David
机构：
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2017年 / 14卷 / 04期
关键词：
D O I：
10.1038/nrclinonc.2017.19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [21] The effect of anti-HER2 therapy in biventricular deformation mechanics
    Keramida, K.
    Bingcang, J.
    Wensel, R.
    Nihoyannopoulos, P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1305 - 1305
  • [22] Targeting the mevalonate pathway in HER2+breast cancer to overcome resistance and enhance anti-HER2 therapy efficacy
    Sethunath, Vidyalakshmi
    Hu, Huizhong
    DeAngelis, Carmine
    Veeraraghavan, Jamunarani
    Qin, Lanfang
    Shea, Martin
    Mitchell, Tamika
    Nanda, Sarmistha
    Pereira, Resel
    Hilsenbeck, Susan G.
    Rimawi, Mothaffar F.
    Osborne, Kent C.
    Schiff, Rachel
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Optimising anti-HER2 therapy in early breast cancer
    Piccart, M.
    Bedard, P.
    de Azambuja, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 34 - 34
  • [24] Cardiac safety of simultaneous anti-HER2 and anthracycline therapy
    Jafri, Mariam
    Rea, Daniel
    BREAST CANCER MANAGEMENT, 2016, 5 (01) : 21 - 29
  • [25] Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
    Kadri Altundag
    Journal of Neuro-Oncology, 2017, 135 : 639 - 639
  • [26] Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
    Altundag, Kadri
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 639 - 639
  • [27] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [28] INFLUENCE OF ANTI-HER2/NEU THERAPY ON GENE ANALYSIS OF CIRCULATING EPITHELIAL TUMOR CELLS (CETC) UNDER THE INFLUENCE OF ANTI-HER2/NEU THERAPY
    Pachmann, K.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 386 - 386
  • [29] Evaluation of an Anti-HER2 Nanobody Labeled with 225AC for Targeted α-Particle Therapy of Cancer
    Pruszynski, Marek
    D'Huyvetter, Matthias
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Lahoutte, Tony
    MOLECULAR PHARMACEUTICS, 2018, 15 (04) : 1457 - 1466
  • [30] Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.
    Loft, Matthew
    Lok, Sheau Wen
    De Boer, Richard H.
    Malik, Laeeq
    Greenberg, Sally
    Yeo, Belinda
    Anton, Angelyn
    Nott, Louise M.
    Richardson, Gary Edward
    Collins, Ian M.
    Torres, Javier
    Barnett, Frances Sarah
    Devitt, Bianca Alix
    Gibbs, Peter
    Gately, Lucy
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345